Compare NNNN & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | OLPX |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | 2021 |
| Metric | NNNN | OLPX |
|---|---|---|
| Price | $31.82 | $2.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $1.89 |
| AVG Volume (30 Days) | 14.1K | ★ 2.8M |
| Earning Date | 04-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $422,960,000.00 |
| Revenue This Year | N/A | $2.95 |
| Revenue Next Year | N/A | $3.39 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | ★ 0.07 |
| 52 Week Low | $7.58 | $0.99 |
| 52 Week High | $55.65 | $2.05 |
| Indicator | NNNN | OLPX |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 63.95 |
| Support Level | $26.31 | $2.02 |
| Resistance Level | $44.06 | N/A |
| Average True Range (ATR) | 2.86 | 0.01 |
| MACD | 0.59 | -0.01 |
| Stochastic Oscillator | 70.78 | 75.00 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.